Skip to main content
SpringerLink
Log in

Cost of skin cancer in England

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

This paper estimates the financial cost of skin cancer in England. National Health Service (NHS) costs were calculated by combining published data on health service use by patients with skin cancer with published data on the unit cost of services. Indirect costs arising from individuals’ inability to function in their usual role as a result of skin cancer were estimated from incapacity benefit claims and numbers of registered deaths due to skin cancer. The total costs of skin cancer were around £240 million. Costs to the NHS represented 42% of the total.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Office for National Statistics: Cancer statistics: registrations, series MB1 No. 32. Office for National Statistics, London

  2. ISD Online: Information and Statistics Division, NHS Scotland. http://www.isdscotland.org/isd/1048.html. Accessed 26 June 2008

  3. Welsh Cancer Intelligence and Surveillance Unit: Cancer incidence 2002 report. Welsh Cancer Intelligence and Surveillance Unit (2004)

  4. Northern Ireland Cancer Registry: Cancer incidence and mortality. http://www.qub.ac.uk/research-centres/nicr/Data/OnlineStatistics/Non-MelanomaSkinCancer/. Accessed 26 June 2008

  5. Office for National Statistics: Mortality statistics: cause, series DH2 no. 29. Office for National Statistics, London

  6. Quinn, M., Babb, P., Brock, A., et al.: Cancer trends in England and Wales, 1950–1999. The Stationery Office, London (2001)

  7. http://info.cancerresearchuk.org/healthyliving/sunsmart/. Accessed 26 June 2008

  8. http://www.york.ac.uk/inst/crd/crddatabases.htm. Accessed 26 June 2008

  9. Housman, T.S., Feldman, S.R., Williford, P.M., et al.: Skin cancer is among the most costly of all cancers to treat for the Medicare population. J. Am. Acad. Dermatol. 48(3), 425–429 (2003)

    Article  Google Scholar 

  10. Chen, J.G., Fleischer, A.B., Smith, E.D., et al.: Cost of nonmelanoma skin cancer treatment in the United States. Dermatol. Surg. 27, 1035–1038 (2001)

    Article  Google Scholar 

  11. National Institute for Clinical Excellence: Guide to the methods of technology appraisal (reference N0515). National Institute for Clinical Excellence, London (2004)

  12. Office for Population Censuses and Surveys: Morbidity statistics from general practice: fourth national study 1991–1992, series MB5 no. 3. HMSO, London (1995)

  13. Cancer Research UKL: Cancer stats incidence—UK. Cancer Research, UK (2004)

  14. Stefoski Mikeljevic, J., Johnston, C., Adamson, P.J., Wright, A., Bishop, J., Newton, A., Batman, P., Neal, R.D., Forman, D.: How complete has skin cancer registration been in the UK? A study from Yorkshire. Eur. J. Cancer Prev. 12(2), 125–133 (2004)

    Article  Google Scholar 

  15. Netten, A., Curtis, L.: Unit costs of health and social care 2003. Personal social services research unit. University of Kent, Canterbury (2003)

  16. Department of Health: Hospital episodes statistics, England: financial year 2002–2003. Department of Health, London (2003)

  17. Department of Health: NHS reference costs 2002. Department of Health, London (2003)

  18. Kernick, D.P., Reinhold, D.M., Netten, A.: What does it cost the patient to see the doctor? Br. J. Gen. Pract. 50, 401–403 (2000)

    Google Scholar 

  19. Office for National Statistics: Annual abstract of statistics No. 140. The Stationery Office, London (2004)

  20. Liu, J.L., Maniadakis, N., Gray, A., Rayner, M.: The economic burden of coronary heart disease in the UK. Heart 88, 597–603 (2002)

    Article  Google Scholar 

  21. Bosanquet, N., Sikora, K.: The economics of cancer care in the UK. Lancet. Oncol. 5, 568–574 (2004)

    Article  Google Scholar 

  22. Carter, R., Marks, R., Hill, D.: Could a national skin cancer primary prevention campaign in Australia be worthwhile? An economic perspective. Health. Promot. Int. 14, 73–82 (1999)

    Article  Google Scholar 

  23. Kyle, J.W., Hammitt, J.K., Lim, H.W., et al.: Economic evaluation of the US Environmental Protection Agency’s SunWise program: sun protection education for young children. Pediatrics 121(5), e1074–e1084 (2008)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Economics Research Group, Brunel University, London

    S. Morris

  2. Tanaka Business School, South Kensington Campus, Imperial College, London, SW7 2AZ, UK

    B. Cox

  3. Faculty of Medicine, Imperial College, London, UK

    N. Bosanquet

Authors
  1. S. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Cox
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. Bosanquet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Cox.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morris, S., Cox, B. & Bosanquet, N. Cost of skin cancer in England. Eur J Health Econ 10, 267–273 (2009). https://doi.org/10.1007/s10198-008-0127-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-008-0127-0

Keywords

JEL Classification

Search

Navigation